These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 190357)

  • 1. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):276-99. PubMed ID: 190357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):300-20. PubMed ID: 190358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural studies of the dying-back process. VI. Examination of nerve fibers undergoing giant axonal degeneration in organotypic culture.
    Veronesi B; Peterson ER; Bornstein MB; Spencer PS
    J Neuropathol Exp Neurol; 1983 Mar; 42(2):153-65. PubMed ID: 6827287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone.
    Spencer PS; Schaumburg HH
    J Neurol Neurosurg Psychiatry; 1975 Aug; 38(8):771-5. PubMed ID: 171344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schwann cell proliferation and migration during paranodal demyelination.
    Griffin JW; Drucker N; Gold BG; Rosenfeld J; Benzaquen M; Charnas LR; Fahnestock KE; Stocks EA
    J Neurosci; 1987 Mar; 7(3):682-99. PubMed ID: 3559707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral nervous system in a case of canine giant axonal neuropathy.
    Duncan ID; Griffiths IR
    Neuropathol Appl Neurobiol; 1979; 5(1):25-39. PubMed ID: 219382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric evaluation of degenerative and regenerative changes in isoniazid-induced neuropathy.
    Chua CL; Ohnishi A; Tateishi J; Kuroiwa Y
    Acta Neuropathol; 1983; 60(3-4):183-93. PubMed ID: 6310925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral nerve changes induced by methyl n-butyl ketone and potentiation by methyl ethyl ketone.
    Saida K; Mendell JR; Weiss HS
    J Neuropathol Exp Neurol; 1976 May; 35(3):207-25. PubMed ID: 178832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive axonopathy: an inherited neuropathy of boxer dogs. Quantitative and morphometric analysis of the peripheral nerve lesion.
    Griffiths IR; Kyriakides E; Scott J
    J Neurol Sci; 1986 Aug; 75(1):69-88. PubMed ID: 3018174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study.
    Schaumburg HH; Spencer PS
    Brain; 1976 Jun; 99(2):183-92. PubMed ID: 186151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone.
    Spencer PS; Schaumburg HH; Raleigh RL; Terhaar CJ
    Arch Neurol; 1975 Apr; 32(4):219-22. PubMed ID: 1124984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural studies of the dying-back process. V. Axonal neurofilaments accumulate at sites of 2,5-hexanedione application: evidence for nerve fibre dysfunction in experimental hexacarbon neuropathy.
    Politis MJ; Pellegrino RG; Spencer PS
    J Neurocytol; 1980 Aug; 9(4):505-16. PubMed ID: 7192310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental neuropathy due to acrilamide. Histological and ultrastructural studies (author's transl)].
    Simonati A; Terzian H; Rizzuto N
    Riv Patol Nerv Ment; 1978 Sep; 98(4):213-27. PubMed ID: 217078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Giant axonal neuropathy" caused by industrial chemicals: neurofilamentous axonal masses in man.
    Davenport JG; Farrell DF; Sumi M
    Neurology; 1976 Oct; 26(10):919-23. PubMed ID: 183168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral neuropathy in the diabetic mutant mouse. An ultrastructural study.
    Sima AA; Robertson DM
    Lab Invest; 1979 Jun; 40(6):627-32. PubMed ID: 449272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy.
    Lehning EJ; Dyer KS; Jortner BS; LoPachin RM
    Toxicol Appl Pharmacol; 1995 Nov; 135(1):58-66. PubMed ID: 7482540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal attenuation and secondary segmental demyelination in myeloma neuropathies.
    Ohi T; Kyle RA; Dyck PJ
    Ann Neurol; 1985 Mar; 17(3):255-61. PubMed ID: 2986526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,5-Hexanedione alters elemental composition and water content of rat peripheral nerve myelinated axons.
    LoPachin RM; Lehning EJ; Stack EC; Hussein SJ; Saubermann AJ
    J Neurochem; 1994 Dec; 63(6):2266-78. PubMed ID: 7964747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropathology of polyneuropathies].
    Seitelberger F
    Wien Klin Wochenschr Suppl; 1984; 147():3-5. PubMed ID: 6328777
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 41.